Your browser doesn't support javascript.
loading
Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating disease.
Macaron, Gabrielle; Khoury, Jean; Hajj-Ali, Rula A; Prayson, Richard A; Srivastava, Sunil; Ehlers, Justis P; Mamsa, Hafsa; Liszewski, M Kathryn; Jen, Joanna C; Bermel, Robert A; Ontaneda, Daniel.
Afiliação
  • Macaron G; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA; Faculty of Medicine, Université Saint Joseph de Beyrouth, Beirut, Lebanon. Electronic address: gabrielle.macaron@hdf.usj.edu.lb.
  • Khoury J; Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hajj-Ali RA; Department of Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH, USA.
  • Prayson RA; Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Srivastava S; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Ehlers JP; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Mamsa H; Department of Neurology, University of California, Los Angeles, CA, USA.
  • Liszewski MK; Division of Rheumatology, Department of Medicine, Washington University, School of Medicine, Saint Louis, MO, USA.
  • Jen JC; Department of Neurology, University of California, Los Angeles, CA, USA.
  • Bermel RA; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.
  • Ontaneda D; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. Electronic address: ontaned@ccf.org.
Mult Scler Relat Disord ; 52: 103015, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34044261
ABSTRACT
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare fatal autosomal dominant vasculopathy associated with mutations in the TREX1 gene. Only one de novo case has been reported in the literature. We report the long-term clinical, radiological, and pathological presentation of a patient with a de novo and novel mutation in this gene. Description of the clinical, genetic, imaging and pathologic characteristics is important to better characterize RVCL-S and prevent unnecessary interventions. RVCL-S should be considered in patients with tumefactive brain lesions unresponsive to immunotherapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Doenças Desmielinizantes / Leucoencefalopatias Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Doenças Desmielinizantes / Leucoencefalopatias Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2021 Tipo de documento: Article